Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00450918 · ClinicalTrials.gov registry record
Evaluating Progression of and Diagnostic Tools for Primary Ciliary Dyskinesia in Children and Adolescents
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 150
- Enrollment target
NCT00450918: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT00450918 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00450918 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
Mucociliary clearance, in which mucus secretions are cleared from the breathing airways, is the primary defense mechanism for the lungs. Inhaled particles, including microbes that can cause infections, are normally entrapped in mucus on the airway surfaces and then cleared out by the coordinated action of tiny hair-like structures called cilia. Individuals with primary ciliary dyskinesia (PCD) have defective mucociliary clearance, which in turn leads to lung infections and disease. The purpose of this study is to determine how lung disease progresses over time in children and adolescents with PCD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2006-08 |
| Est. Completion | 2019-08 |
What the finished NCT00450918 record still lists
NCT00450918 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00450918 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00450918 about?
NCT00450918 is a clinical study titled "Evaluating Progression of and Diagnostic Tools for Primary Ciliary Dyskinesia in Children and Adolescents". Mucociliary clearance, in which mucus secretions are cleared from the breathing airways, is the primary defense mechanism for the lungs. Inhaled particles, including microbes that can cause infections, are normally entrapped in mucus on the airway surfaces and then cleared out by the coordinated act...
What is the current status of trial NCT00450918?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2006-08. Estimated completion is 2019-08.
Who is sponsoring clinical trial NCT00450918?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia